Das Saroj Kumar, Sahoo Tapan Kumar, Parija Sucheta, Majumdar Saroj Kumar Das, Parida Dillip Kumar
Senior Resident, Department of Radiation Oncology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Associate Professor, Department of Ophthalmology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
J Clin Diagn Res. 2017 Mar;11(3):XD04-XD06. doi: 10.7860/JCDR/2017/22533.9446. Epub 2017 Mar 1.
Vision impairment as an initial presentation detecting choroid metastasis in primary lung cancer is rare. Prevention or treatment of visual loss and improvement in quality of life can be achieved by treatment of intraocular metastasis. The survival of the patient in choroid metastasis with lung primary is poor with the median survival being 3.3 months. However, proper treatment may increase the quality of life and survival to an extent. We report a case of adenocarcinoma of lung in a female patient, presented initially with visual impairment as a result of choroidal metastasis and treated with external beam radiotherapy for choroidal metastasis followed by palliative chemotherapy. The patient was survived with improved vision and quality of life since last 12 months of diagnosis.
以视力损害作为首发表现来检测原发性肺癌脉络膜转移的情况较为罕见。通过治疗眼内转移灶可实现预防或治疗视力丧失并改善生活质量。肺原发性脉络膜转移患者的生存期较差，中位生存期为3.3个月。然而，恰当的治疗在一定程度上可提高生活质量和延长生存期。我们报告一例女性肺腺癌患者，最初因脉络膜转移而出现视力损害，接受了脉络膜转移灶的外照射放疗，随后进行姑息化疗。自诊断后的过去12个月以来，该患者视力改善且生活质量提高，得以存活。
